APZ Aptilon Corporation

MONTREAL, May 30, 2012 /CNW/ - Aptilon Corporation ("Aptilon or the "Company") , a leader in online access, engagement and interaction with physicians and healthcare professionals on behalf of pharmaceutical and life sciences companies, today announced that the filing of  the Company's interim financial report for the period ended March 31, 2012, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the "Interim Filings".) will not be made by the required filing deadline of May 30, 2012 (the "Filing Deadline").The Autorité des marchés financiers approved a management cease-trade order on May 4 regarding the delay in filing the annual financial statements for the year ended December 31, 2011. The company expects that the Interim Filings will be made simultaneously with the annual filings or shortly thereafter. About Aptilon Corporation Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through: video and mobile detailing, ReachNet(SM) Physician Access Channel, the DMD database and permission-based email services. Top US pharmaceutical companies and respected healthcare organizations have adopted Aptilon's solutions to market to, engage and interact with leading healthcare practitioners. For more information, visit www.aptilon.com. ReachNet(SM) is a service mark of Aptilon Corporation, other trademarks are the property of their respective owners. Forward-looking statements This news release may contain forward-looking statements. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Aptilon Corporation CONTACT: Mr. Denis MartineauPresidentAptilon Corporation1-888-544-8866investors@aptilon.com

Copyright